Alzheimer disease pathology and the cerebrospinal fluid proteome

被引:0
|
作者
Loïc Dayon
Antonio Núñez Galindo
Jérôme Wojcik
Ornella Cominetti
John Corthésy
Aikaterini Oikonomidi
Hugues Henry
Martin Kussmann
Eugenia Migliavacca
India Severin
Gene L. Bowman
Julius Popp
机构
[1] Nestlé Institute of Health Sciences,Old Age Psychiatry, Department of Psychiatry
[2] Precision for Medicine,Department of Laboratories
[3] CHUV,Geriatric Psychiatry, Department of Mental Health and Psychiatry
[4] CHUV,Present address: Liggins Institute
[5] HUG,undefined
[6] University of Auckland,undefined
来源
Alzheimer's Research & Therapy | / 10卷
关键词
Alzheimer disease; Amyloid; Biomarker; Cerebrospinal fluid; CSF; Mass spectrometry; Proteomics; Tau; Tandem mass tag;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: More to Come?
    Zetterberg, Henrik
    Blennow, Kaj
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 : S361 - S369
  • [32] Clinical use of cerebrospinal fluid biomarkers in Alzheimer's disease
    Zetterberg, Henrik
    Lunn, Michael P.
    Herukka, Sanna-Kaisa
    BIOMARKERS IN MEDICINE, 2012, 6 (04) : 371 - 376
  • [33] Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease
    Yang, Yue
    Keene, C. Dirk
    Peskind, Elaine R.
    Galasko, Douglas R.
    Hu, Shu-Ching
    Cudaback, Eiron
    Wilson, Angela M.
    Li, Ge
    Yu, Chang-En
    Montine, Kathleen S.
    Zhang, Jing
    Baird, Geoffrey S.
    Hyman, Bradley T.
    Montine, Thomas J.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2015, 74 (07) : 672 - 687
  • [34] A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium
    Somers, Charisse
    Struyfs, Hanne
    Goossens, Joery
    Niemantsverdriet, Ellis
    Luyckx, Jill
    De Roeck, Naomi
    De Roeck, Ellen
    De Vil, Bart
    Cras, Patrick
    Martin, Jean-Jacques
    De Deyn, Peter-Paul
    Bjerke, Maria
    Engelborghs, Sebastiaan
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 54 (01) : 383 - 395
  • [35] Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease
    Zhang, J
    Goodlett, DR
    Quinn, JF
    Peskind, E
    Kaye, JA
    Zhou, Y
    Pan, C
    Yi, E
    Eng, J
    Wang, Q
    Aebersold, RH
    Montine, TJ
    JOURNAL OF ALZHEIMERS DISEASE, 2005, 7 (02) : 125 - 133
  • [36] Cerebrospinal fluid biomarkers of Alzheimer's disease
    Fagan, Anne M.
    Holtzman, David M.
    BIOMARKERS IN MEDICINE, 2010, 4 (01) : 51 - 63
  • [37] Cerebrospinal fluid biomarkers in Alzheimer's disease
    Hugon, Jacques
    Dumurgier, Julien
    Cognat, Emmanuel
    Paquet, Claire
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2018, 202 (1-2): : 307 - 318
  • [38] Cerebrospinal Fluid Biomarkers in Alzheimer's Disease Families with PSEN1 Mutations
    Fortea, Juan
    Llado, Albert
    Bosch, Beatriz
    Antonell, Anna
    Oliva, Rafael
    Luis Molinuevo, Jose
    Sanchez-Valle, Raquel
    NEURODEGENERATIVE DISEASES, 2011, 8 (04) : 202 - 207
  • [39] The Associations of Cerebrospinal Fluid ApoE and Biomarkers of Alzheimer's Disease: Exploring Interactions With Sex
    Liu, Ying
    Song, Jing-Hui
    Xu, Wei
    Hou, Xiao-He
    Li, Jie-Qiong
    Yu, Jin-Tai
    Tan, Lan
    Chi, Song
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [40] What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease?
    Gaunitz, Stefan
    Tjernberg, Lars O.
    Schedin-Weiss, Sophia
    BIOMOLECULES, 2021, 11 (06)